NS is also a recognized risk factor for obstructive sleep apnea, which contributes to insulin resistance and systemic inflammation via intermittent hypoxia-induced oxidative stress and sympathetic activation [48,49]. This evidence concerns the gene INS and obstructive sleep apnea syndrome.